Assignee
Novitium Pharma LLC
US·4 granted patents·4 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
8 records- 0173US2025375376A1Stable oral liquid composition of terazosinNovitium Pharma LLC·Filed 2025·Application pending·0 cites
- 0271US11628143B1Tablet for oral suspensionNovitium Pharma LLC·Filed 2022·Granted Apr 18, 2023·0 cites·19 claims
- 0371US2024293325A1Tablet for oral suspensionNovitium Pharma LLC·Filed 2023·Application pending·0 cites
- 0469US2023398078A1Tablet for oral suspensionNovitium Pharma LLC·Filed 2023·Application pending·0 cites
- 0565US12427108B2Stable oral liquid composition of terazosinNovitium Pharma LLC·Filed 2021·Granted Sep 30, 2025·0 cites·17 claims
- 0662US11224572B1Stable oral liquid composition of terazosinNovitium Pharma LLC·Filed 2021·Granted Jan 18, 2022·0 cites·20 claims
- 0757US11878022B2Hydrochlorothiazide compositionsNovitium Pharma LLC·Filed 2022·Granted Jan 23, 2024·0 cites·20 claims
- 0844US2022184094A1Hydrochlorothiazide compositionsNovitium Pharma LLC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Novitium Pharma LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →